Roche NimbleGen Add Multiplex Gene Expression Arrays and Services to Growing Product Portfolio

Mannheim, (PresseBox) - Roche NimbleGen Inc., a fully integrated part of Roche Applied Science today announced the addition of 4-plex eukaryotic gene expression analysis microarrays and services to its growing suite of genomic and epigenetic analysis tools.

The NimbleChip™ Multiplex Arrays enable researchers to simultaneously hybridize and analyze samples in four replicate arrays on a single slide to provide a high-performance yet cost-effective approach to gene expression analysis. Roche NimbleGen's unique ability to make long oligonucleotide probes (60mer) in combination with high density sub-arrays of 72,000 probes each provides comprehensive coverage of entire genomes with multiple probes per gene. The averaging of the results from multiple probes (typically 3-7 probes per gene) provides improved statistical confidence and can dramatically reduce the impact of inconsistent probe behavior, ensuring high specificity, sensitivity, and reproducibility compared to platforms that offer only one to two probes per gene.

Whole-genome designs are available in multiplex format for a broad range of species, including human, mouse, rat, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Arabidopsis thaliana, Caenorhabditis elegans, and Drosophila melanogaster. Researchers can also request custom gene expression arrays in the 4-plex format for any eukaryote with a well annotated genome.

"From the first experiment we found that the Roche NimbleGen multiplex platform was easy to use in a standard laboratory setting. The results are extremely reproducible, and control probes provide reliable identification of the samples loaded on each of the sub-arrays," said beta collaborator Dr. Jason Lieb, assistant professor at the Carolina Center for Genome Sciences and The University of North Carolina, Chapel Hill. "We will certainly look to this platform as an economical way to perform many experiments in-house."

Roche NimbleGen is a leading innovator, manufacturer, and supplier of a proprietary suite of DNA microarrays, consumables, instruments, and services. Roche NimbleGen uniquely produces high-density arrays of long oligo probes that provide greater information content and higher data quality necessary for studying the full diversity of genomic and epigenomic variation. The improved performance is made possible by Roche NimbleGen's proprietary Maskless Array Synthesis (MAS) technology, which uses digital light processing and rapid, high-yield photochemistry to synthesize long oligo, high-density DNA microarrays with extreme flexibility. For more information about Roche NimbleGen, please visit the company's website at www.nimblegen.com.

Diese Pressemitteilungen könnten Sie auch interessieren

Weitere Informationen zum Thema "Biotechnik":

Künstliche Intelligenz optimiert das Mobilfunknetz

Das Mo­bil­funk­netz, ein kom­ple­xes Kon­strukt aus Mo­bil­funk­stand­or­ten und Net­z­e­le­men­ten, sorgt da­für, dass Men­schen je­der­zeit und übe­rall mit­ein­an­der te­le­fo­nie­ren und ih­re di­gi­ta­len An­wen­dun­gen nut­zen kön­nen. Die In­stand­hal­tung, Über­prü­fung und Opti­mie­rung ei­ner solch viel­schich­ti­gen Struk­tur er­for­dert je­de Men­ge men­sch­li­ches und tech­ni­sches Know-how. Um kom­ple­xe Zu­sam­men­hän­ge im Mo­bil­funk­netz noch bes­ser zu ver­ste­hen, setzt Te­le­fó­ni­ca Deut­sch­land seit ei­ni­ger Zeit Al­go­rith­men und Künst­li­che In­tel­li­genz (KI) ein.

Weiterlesen

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.


Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.